Stilbene analogs as inducers of apolipoprotein-I transcription
- 1 May 2010
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 45 (5) , 2018-2023
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Therapies to Increase ApoA-I and HDL-Cholesterol LevelsDrug Target Insights, 2008
- New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol TransportCirculation Research, 2005
- Polyphenols and prevention of cardiovascular diseasesCurrent Opinion in Lipidology, 2005
- Regulation of apoA-I gene expressionJournal of Lipid Research, 2004
- Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary SyndromesJAMA, 2003
- High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from framingham to the veterans affairs high-density lipoprotein intervention trialThe American Journal of Cardiology, 2000
- Fine Feathers Make Fine Birds: The Heck Reaction in Modern GarbAngewandte Chemie International Edition, 1995
- 3‐(Cyclohexenonyl)‐4‐(4‐hydroxyphenyl)‐hexanes: Antiandrogenes Derived from the Estrogen HexestrolArchiv der Pharmazie, 1990
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- Synthesis of hydroxy derivatives of 2,5-diaryl-1,3,4-oxadiazolesChemistry of Heterocyclic Compounds, 1972